Table 1.
Cancer type | N | M/F | Age (years) | Weight (lbs) | Ascorbic acid, post (mM) | Ascorbic acid, pre (mM) | Ascorbic acid, minimum pre (mM) |
---|---|---|---|---|---|---|---|
Bladder |
10 |
8/2 |
32–80 |
160–192 |
5.00 |
0.078 |
0.045 |
Brain |
12 |
3/9 |
26–66 |
126–137 |
6.73 |
0.051 |
0.045 |
Breast |
105 |
1/133 |
38–72 |
104–190 |
6.57 |
0.076 |
0.023 |
Breast, metastatic |
28 |
0/28 |
36–64 |
93–250 |
5.45 |
0.060 |
0.017 |
Chronic Lymphocytic Leukemia |
15 |
8/7 |
50–67 |
125–213 |
5.52 |
0.059 |
0.023 |
Colon |
34 |
23/11 |
50–78 |
110–280 |
5.46 |
0.063 |
0.017 |
Colon, metastatic |
26 |
16/10 |
50–69 |
106–200 |
6.23 |
0.062 |
0.028 |
Esophagus |
5 |
5/0 |
48–77 |
ND |
5.99 |
0.080 |
0.068 |
Esophagus, metastatic |
5 |
5/0 |
50–63 |
114–280 |
6.11 |
0.055 |
0.011 |
Liver |
8 |
5/3 |
14–58 |
99–157 |
5.78 |
0.057 |
0.034 |
Liver, metastatic |
7 |
3/4 |
50–69 |
85–160 |
5.90 |
0.052 |
0.028 |
Lung |
43 |
25/18 |
49–75 |
104–290 |
5.81 |
0.051 |
0.011 |
Lung, metastatic |
20 |
10/10 |
25–78 |
107–178 |
5.07 |
0.060 |
0.017 |
lymphoma (non-Hodgkin’s) |
6 |
1/5 |
40–65 |
120–159 |
5.13 |
0.077 |
0.063 |
Melanoma |
11 |
3/8 |
26–72 |
130–207 |
5.26 |
0.068 |
0.063 |
Ovarian |
36 |
0/36 |
31–76 |
108–217 |
6.59 |
0.058 |
0.017 |
Pancreas |
16 |
11/5 |
58–80 |
149–200 |
5.65 |
0.051 |
0.028 |
Pancreas, metastatic |
11 |
7/4 |
65–80 |
132–174 |
5.13 |
0.068 |
0.045 |
Prostate |
64 |
64/0 |
59–89 |
147–250 |
5.61 |
0.063 |
0.017 |
Prostate, metastatic |
7 |
7/0 |
59–88 |
150–225 |
4.64 |
0.059 |
0.023 |
Renal |
17 |
10/7 |
51–76 |
72–229 |
6.08 |
0.055 |
0.040 |
Renal, metastatic |
13 |
7/6 |
39–68 |
ND |
5.89 |
0.063 |
0.040 |
Sarcoma |
7 |
5/2 |
21–75 |
90–163 |
4.98 |
0.045 |
0.023 |
Skin |
6 |
6/0 |
54–76 |
175–211 |
5.54 |
0.051 |
0.028 |
Stomach |
5 |
4/1 |
33–77 |
ND |
4.75 |
0.051 |
0.028 |
Throat |
7 |
4/3 |
34–80 |
ND |
5.40 |
0.063 |
0.034 |
Thymus |
7 |
4/3 |
48–73 |
48–73 |
5.39 |
0.068 |
0.051 |
Uterus | 7 | 0/7 | 52–70 | 99–173 | 6.62 | 0.068 | 0.051 |